GlassScriptPhysician profile
Tamara V Toidze
NPI 1942581616
$6,510.94
in general payments reported to CMS, 2019-2025
18 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $109 · 2021: $3,253 · 2022: $294 · 2023: $809 · 2024: $802 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,992.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,003.86 | 2021 | |
| Medtronic, INC. | $1,615.80 | 2022-2025 | Interstim |
| Boston Scientific Corporation | $551.17 | 2019-2025 | Upsylon, Advantage System |
| Coloplast Corp | $348.13 | 2019-2022 | |
| Baxter Healthcare | $228.51 | 2021-2023 | Tisseel |
| Applied Medical Resources Corporation | $194.13 | 2024 | Gelpoint V-Path |
| Astellas Pharma US INC | $175.90 | 2019-2020 | |
| Therapeuticsmd, INC. | $116.55 | 2019-2022 | |
| Abbvie INC. | $80.48 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $29.93 | 2019 | |
| Organon LLC | $29.32 | 2021 | |
| Exeltis, USA INC. | $29.14 | 2021 | |
| Avion Pharmaceuticals | $23.46 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.91 | 2021 | |
| Merck Sharp & Dohme LLC | $19.41 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $17.02 | 2020 | |
| Axonics, INC. | $16.24 | 2023 | Bulkamid, Axonics |
| Coopersurgical, INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Toidze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.